AdaptHealth former CFO proposes $448K share sale

Jason Allen Clemens also reported selling 169,779 common shares on November 5, 2026, for $1,260,743.41.

Available on EDGAR 11/06/2026 - 04:18 PM EST Accepted by SEC EDGAR 11/06/2026 - 04:17 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

AdaptHealth Corp. (AHCO) lists a proposed sale by former CFO Jason Allen Clemens of 60,978 common shares, with an aggregate market value of $447,510.44; Morgan Stanley Smith Barney LLC is identified as the broker. The securities information also lists five common-stock entries for restricted-stock vesting under a registered plan, with services rendered as the stated acquisition basis.

Key Figures

Common shares proposed for sale: 60,978 shares Aggregate market value: $447,510.44 Common shares sold: 169,779 shares +1 more

4 metrics

Common shares proposed for sale 60,978 shares Proposed sale

Aggregate market value $447,510.44 Proposed sale

Common shares sold 169,779 shares Past-three-month sales; November 5, 2026

Value of shares sold $1,260,743.41 Past-three-month sales; November 5, 2026

Key Terms

Rule 144, Restricted Stock Vesting Under a Registered Plan, Services Rendered

3 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting Under a Registered Plan financial

"Restricted Stock Vesting Under a Registered Plan"

Services Rendered financial

"Services Rendered"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AHCO shares does former CFO Jason Allen Clemens plan to sell?

Jason Allen Clemens is listed as planning to sell 60,978 common shares, with an aggregate market value of $447,510.44. Morgan Stanley Smith Barney LLC is identified as the broker.

How many AHCO shares did Jason Allen Clemens report selling recently?

The reported past-three-month sales include 169,779 common shares sold on November 5, 2026, for $1,260,743.41.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001820867
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ADAPTHEALTH CORP.
SEC File Number	001-38399
Address of Issuer	555 East North Lane Suite 5075 Conshohocken PENNSYLVANIA 19428
Phone	(610) 424-4515
Name of Person for Whose Account the Securities are To Be Sold	JASON A CLEMENS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former CFO

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	60978	447510.44	136525348	11/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/28/2024	Restricted Stock Vesting Under a Registered Plan	Issuer			1544	02/28/2024	Services Rendered
Common	10/11/2024	Restricted Stock Vesting Under a Registered Plan	Issuer			9578	10/11/2024	Services Rendered
Common	02/01/2025	Restricted Stock Vesting Under a Registered Plan	Issuer			33011	02/01/2025	Services Rendered
Common	02/01/2025	Restricted Stock Vesting Under a Registered Plan	Issuer			8555	02/01/2025	Services Rendered
Common	02/01/2025	Restricted Stock Vesting Under a Registered Plan	Issuer			8290	02/01/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JASON A CLEMENS 555 East North Lane Suite 5075 Conshohocken PA 19428	Common	11/05/2026	169779	1260743.41

144: Remarks and Signature

Remarks
Date of Notice	11/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jason Allen Clemens
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)